1. Nucci M, Marr KA. Emerging fungal diseases. Clin Infect Dis. 2005. 41:521–526.
Article
2. Malani AN, Kauffman CA. Changing epidemiology of rare mould infections: implications for therapy. Drugs. 2007. 67:1803–1812.
3. Nucci M. Emerging moulds: Fusarium, Scedosporium and Zygomycetes in transplant recipients. Curr Opin Infect Dis. 2003. 16:607–612.
Article
4. Summerbell RC, Levesque CA, Seifert KA, Bovers M, Fell JW, Diaz MR, et al. Microcoding: the second step in DNA barcoding. Philos Trans R Soc Lond B Biol Sci. 2005. 360:1897–1903.
Article
5. Balajee SA, Borman AM, Brandt ME, Cano J, Cuenca-Estrella M, Dannaoui E, et al. Sequence-based identification of Aspergillus, fusarium, and mucorales species in the clinical mycology laboratory: where are we and where should we go from here? J Clin Microbiol. 2009. 47:877–884.
6. Ciardo DE, Schar G, Altwegg M, Bottger EC, Bosshard PP. Identification of moulds in the diagnostic laboratory--an algorithm implementing molecular and phenotypic methods. Diagn Microbiol Infect Dis. 2007. 59:49–60.
Article
7. Ciardo DE, Lucke K, Imhof A, Bloemberg GV, Böttger EC. Systematic internal transcribed spacer sequence analysis for identification of clinical mold isolates in diagnostic mycology: a 5-year study. J Clin Microbiol. 2010. 48:2809–2813.
Article
8. Iwen PC, Hinrichs SH, Rupp ME. Utilization of the internal transcribed spacer regions as molecular targets to detect and identify human fungal pathogens. Med Mycol. 2002. 40:87–109.
Article
9. Atkins SD, Clark IM. Fungal molecular diagnostics: a mini review. J Appl Genet. 2004. 45:3–15.
10. Li DM, de Hoog GS, Saunte DM, van den Ende AH, Chen XR. Coniosporium epidermidis sp. nov., a new species from human skin. Stud Mycol. 2008. 61:131–136.
Article
11. Barton RC, Borman AM, Johnson EM, Houbraken J, Hobson RP, Denton M, et al. Isolation of the fungus Geosmithia argillacea in sputum of people with cystic fibrosis. J Clin Microbiol. 2010. 48:2615–2617.
12. Giraud S, Pihet M, Razafimandimby B, Carrere J, Degand N, Mely L, et al. Geosmithia argillacea: an emerging pathogen in patients with cystic fibrosis. J Clin Microbiol. 2010. 48:2381–2386.
13. Hinrikson HP, Hurst SF, Lott TJ, Warnock DW, Morrison CJ. Assessment of ribosomal large-subunit D1-D2, internal transcribed spacer 1, and internal transcribed spacer 2 regions as targets for molecular identification of medically important Aspergillus species. J Clin Microbiol. 2005. 43:2092–2103.
14. Graser Y, Kuijpers AF, Presber W, De Hoog GS. Molecular taxonomy of Trichophyton mentagrophytes and T. tonsurans. Med Mycol. 1999. 37:315–330.
Article
15. Sun PL, Hsieh HM, Ju YM, Jee SH. Molecular characterization of dermatophytes of the Trichophyton mentagrophytes complex found in Taiwan with emphasis on their correlation with clinical observations. Br J Dermatol. 2010. 163:1312–1318.
Article
16. Heidemann S, Monod M, Graser Y. Signature polymorphisms in the internal transcribed spacer region relevant for the differentiation of zoophilic and anthropophilic strains of Trichophyton interdigitale and other species of T. mentagrophytes sensu lato. Br J Dermatol. 2010. 162:282–295.
17. Clinical and Laboratory Standards Institute. Interpretive criteria for identification of bacteria and fungi by DNA target sequencing: approved guideline. CLSI document MM18-A. 2008. Wayne, PA: Clinical and Laboratory Standards Institute.
18. Balajee SA, Gribskov JL, Hanley E, Nickle D, Marr KA. Aspergillus lentulus sp. nov., a new sibling species of A. fumigatus. Eukaryot Cell. 2005. 4:625–632.
19. Montenegro G, Sánchez Puch S, Jewtuchowicz VM, Pinoni MV, Relloso S, Temporitti E, et al. Phenotypic and genotypic characterization of Aspergillus lentulus and Aspergillus fumigatus isolates in a patient with probable invasive aspergillosis. J Med Microbiol. 2009. 58:391–395.
Article